Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewC 75 is a synthetic inhibitor of fatty acid synthase (FASN); inhibits fatty acid synthesis in vitro and in vivo. Displays anorectic effects. Induces apoptosis in MCF-7 xenografts and exhibits antitumor activity.
C 75 is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.
M. Wt | 254.32 |
Formula | C14H22O4 |
Storage | Store at +4°C |
Purity | ≥95% (HPLC) |
CAS Number | 191282-48-1 |
PubChem ID | 90488767 |
InChI Key | VHOGWRFOUWVZQX-FBVLPHPLSA-N |
Smiles | C=C([C@@H]([C@](O)=O)[C@H](CCCCCCCC)O1)C1=O.C=C([C@H](C(O)=O)[C@@H](CCCCCCCC)O2)C2=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
1eq. NaOH | 25.43 | 100 | |
DMSO | 25.43 | 100 |
The following data is based on the product molecular weight 254.32. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 3.93 mL | 19.66 mL | 39.32 mL |
5 mM | 0.79 mL | 3.93 mL | 7.86 mL |
10 mM | 0.39 mL | 1.97 mL | 3.93 mL |
50 mM | 0.08 mL | 0.39 mL | 0.79 mL |
References are publications that support the biological activity of the product.
Zhou et al (2003) Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res. 63 7330 PMID: 14612531
Takahashi et al (2004) The anorexigenic fatty acid synthase inhibitor, C45, is a nonspecific neuronal activator. Endocrinology 145 184 PMID: 14512433
Kuhajda et al (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc.Natl.Acad.Sci. 97 3450
Thupari et al (2004) Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. Am.J.Physiol.Endocrinol.Metab. 287 97
If you know of a relevant reference for C 75, please let us know.
Keywords: C 75, C 75 supplier, trans-C75, transC75, C75, fatty, acid, synthase, inhibitor, enzyme, FASanorectic, anorexigenic, neuronal, activator, inhibits, inhibitors, fat, obese, apoptosis, anti-tumor, FASN, trans-C, 75, Apoptosis, Inducers, Fatty, Acid, Synthase, 2489, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for C 75 include:
Sadowski et al (2014) The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer. Oncotarget 5 9362 PMID: 25313139
Do you know of a great paper that uses C 75 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review C 75 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including: